Quantitative Proteomics Analysis of Sporadic Medullary Thyroid Cancer Reveals FN1 as a Potential Novel Candidate Prognostic Biomarker [PDF]
Shaohua Zhan +3 more
openalex +1 more source
Serum calcitonin estimation in medullary thyroid cancer: basal or stimulated levels? [PDF]
Chantal Daumerie +2 more
openalex +1 more source
Clinical relevance of 18 F-FDG PET/CT in the postoperative follow-up of patients with history of medullary thyroid cancer [PDF]
Jelena Šaponjski +4 more
openalex +1 more source
Laboratory diagnostics and follow-up of medullary thyroid cancer. [PDF]
Giovanella L +3 more
europepmc +1 more source
Serum calcitonin nadirs to undetectable levels within 1 month of curative surgery in medullary thyroid cancer [PDF]
Fernanda Accioly de Andrade +8 more
openalex +1 more source
Pembrolizumab in recurrent or metastatic medullary thyroid cancer. [PDF]
Del Rivero J +9 more
europepmc +1 more source
Differences in the aggressiveness of familial versus sporadic non-medullary thyroid cancer: An unresolved controversy. [PDF]
Miasaki FY +5 more
europepmc +1 more source
174. Efficacy of various chemotherapy schemes in treatment of advanced medullary thyroid cancer [PDF]
Pavel Roumiantsev +3 more
openalex +1 more source

